KILITCH Intraday Analysis...

KILITCH Share Price

Open 46.00 Change Price %
High 50.95 1 Day 2.95 6.36
Low 46.00 1 Week 0.40 0.82
Close 49.30 1 Month 12.50 33.97
Volume 112699 1 Year 9.65 24.34
52 Week High 60.00
52 Week Low 30.65
KILITCH Important Levels
Resistance 2 53.89
Resistance 1 52.00
Pivot 48.75
Support 1 46.60
Support 2 44.71
NSE INDIA Most Active Stocks
JPASSOCIAT 10.20 5.15%
SUZLON 15.70 0.64%
JINDALSTEL 80.20 3.48%
ADANIPOWER 37.85 2.30%
HINDALCO 177.00 3.48%
VEDL 244.40 3.52%
GMRINFRA 12.55 0.00%
BHEL 132.40 3.48%
POWERGRID 198.45 0.35%
NHPC 29.80 -0.50%
More..
NSE INDIA Top Gainers Stocks
RASOYPR 0.20 33.33%
FMNL 45.00 20.00%
INDOTHAI 25.05 19.86%
HOTELRUGBY 4.60 19.48%
OILCOUNTUB 52.05 17.89%
PANACEABIO 148.30 16.59%
ELGIRUBCO 55.95 15.96%
TRIL 437.90 15.42%
WEIZFOREX 244.90 14.81%
JINDCOT 16.85 14.63%
More..
NSE INDIA Top Losers Stocks
VKSPL 0.10 -33.33%
FCSSOFT 0.30 -14.29%
SPYL 1.00 -13.04%
NAKODA 0.40 -11.11%
UNITEDTEA 303.95 -8.55%
AGARIND 332.80 -7.14%
ASIL 0.70 -6.67%
CELESTIAL 21.30 -6.17%
KRIDHANINF 57.75 -6.02%
SUNDARAM 4.05 -5.81%
More..

Kilitch Drugs (India) Limited (NSE: KILITCH)

KILITCH Technical Analysis 3
As on 18th Jan 2017 KILITCH Share Price closed @ 49.30 and we RECOMMEND Buy for LONG-TERM with Stoploss of 37.49 & Buy for SHORT-TERM with Stoploss of 40.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
KILITCH Target for January
1st Target up-side 39.4
2nd Target up-side 41.12
3rd Target up-side 42.84
1st Target down-side 34.5
2nd Target down-side 32.78
3rd Target down-side 31.06
KILITCH Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
KILITCH Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
KILITCH Address
KILITCH
N/A
KILITCH Latest News
Kilitch Drugs India: Outcome of board meeting   Moneycontrol.com   - 12th Feb 15
Novo Informatics receives emerging company award from Karnataka Govt   Business Standard   - 26th May 14
Akorn Reports 2012 Fourth Quarter and Year-End Financial Results   Business Wire (press release)   - 26th Feb 13
Kilitch Drugs To Divest EyeKare Kilitch   DealCurry   - 16th Jan 13
Kilitch Drugs quoting ex-dividend   Moneycontrol.com   - 24th Sep 12
Kilitch Company buys 6.16 lakh shares of Kilitch Drugs   Moneycontrol.com   - 22nd Sep 12
Akorn Completes the Acquisition of Certain Assets of Kilitch Drugs in India   Business Wire (press release)   - 29th Feb 12
After tightening focus, Akorn takes off   Chicago Tribune   - 14th Jan 12
Akorn Enters Into an Agreement to Acquire Certain Assets of Kilitch Drugs in India   Business Wire (press release)   - 06th Oct 11
Kilitch Drugs to enter Rs600 crore eye care market   Daily News & Analysis   - 07th Mar 10
Interactive Technical Analysis Chart Kilitch Drugs (India) Limited ( KILITCH NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Kilitch Drugs (India) Limited
KILITCH Business Profile
Kilitch Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 25.87 crore.The company has reported a consolidated sales of Rs 4.05 crore and a Net Profit of Rs 0.12 crore for the quarter ended Dec 2012.The company management includes Mukund P Mehta - Managing Director, Paresh P Mehta - Joint Managing Director, Nilima Waigankar - Whole Time Director, Bhavin M Mehta - Executive Director, Mukesh Shah - Independent Director, Pankaj Kamdar - Independent Director, Shailesh Chheda - Independent Director, Hemang Engineer - Independent Director, Mira Mehta - Additional Director, Deepu Kesavan Panankattil - Additional Director. It is listed on the BSE with a BSE Code of 524500 and the NSE with an NSE Code of KILITCH.Its Registered office is at C-301/2, MIDC, TTC Industrial area,,Pawane Village Thane,Maharashtra - 400705.Their Registrars are Link Intime India Pvt. Ltd.